AbCellera Biologics Inc.
ABCL
$10.97
$0.625.94%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -164.66M | -143.96M | -146.41M | -171.68M | -165.67M |
| Total Depreciation and Amortization | 32.59M | 30.87M | 28.82M | 2.80M | 33.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.25M | 54.38M | 56.99M | 73.90M | 48.13M |
| Change in Net Operating Assets | -22.12M | -94.56M | -70.69M | -9.57M | 2.83M |
| Cash from Operations | -94.94M | -153.26M | -131.30M | -104.55M | -80.84M |
| Capital Expenditure | -24.73M | -35.97M | -42.77M | -48.56M | -58.15M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 122.62M | 90.70M | 130.52M | 96.87M | 73.67M |
| Cash from Investing | 97.89M | 54.73M | 87.75M | 48.32M | 15.53M |
| Total Debt Issued | 18.08M | 19.30M | 18.08M | 11.87M | 7.65M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.99M | -4.00M | -4.00M | 2.24M | 2.23M |
| Cash from Financing | 25.07M | 15.30M | 14.08M | 14.11M | 9.88M |
| Foreign Exchange rate Adjustments | -722.00K | 469.00K | 1.10M | -1.35M | -442.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.30M | -82.76M | -28.37M | -43.48M | -55.88M |